Future Strategies for Development of Novel BACE Inhibitors: Anti-APP β-Site Antibody and APP Binding Small Molecule Approaches for Alzheimer's Disease

BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease

Volumn , Issue , 2010, Pages 217-234

  Solomon, Beka ^a   Arbel Ornath, Michal ^a   Peters Libeu, Clare ^b   John, Varghese ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Alzheimer's disease (AD), progressive neurodegeneration dementia in elderly; Anti site antibody mediating inhibition of A production via endocytic pathway; Limiting intracellular A formation at early stages of AD development

Indexed keywords

EID: 78650802894     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470594087.ch10     Document Type: Chapter

References (63)

1. Selkoe, D.J. 2001 . Alzheimer ' s disease: genes, proteins, and therapy . Physiol Rev 81 : 741-766 .
2. Hardy, J. and Allsop, D. 1991 . Amyloid deposition as the central event in the aetiology of Alzheimer ' s disease . Trends Pharmacol Sci 12 : 383-388 .
3. Selkoe, D.J. 1996 . Amyloid beta-protein and the genetics of Alzheimer ' s disease . J Biol Chem 271 : 18295-18298 .
4. Hardy, J. 1997 . Amyloid, the presenilins and Alzheimer ' s disease . Trends Neurosci 20 : 154-159 .
5. Hardy, J. and Selkoe, D.J. 2002 . The amyloid hypothesis of Alzheimer ' s disease: progress and problems on the road to therapeutics . Science 297 : 353-356 .
6. Busciglio, J., Lorenzo, A., Yeh, J., and Yankner, B.A. 1995 . Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding . Neuron 14 : 879-888 .
7. Gotz, J., Probst, A., Spillantini, M.G., Schafer, T., Jakes, R., Burki, K., and Goedert, M. 1995 . Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform . Embo J 14 : 1304-1313 .
8. Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., Yen, S.H., Sahara, N., Skipper, L., Yager, D., Eckman, C., Hardy, J., Hutton, M., and McGowan, E. 2001 . Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP . Science 293 : 1487-1491 .
9. Hardy, J., Duff, K., Hardy, K.G., Perez-Tur, J., and Hutton, M. 1998 . Genetic dissection of Alzheimer ' s disease and related dementias: amyloid and its relationship to tau . Nat Neurosci 1 : 355-358 .
10. Ghosh, A.K., Gemma, S., and Tang, J. 2008 . Beta-secretase as a therapeutic target for Alzheimer ' s disease . Neurotherapeutics 5 : 399-408 .
11. Hook, V., Toneff, T., Bogyo, M., Greenbaum, D., Medzihradszky, K.F., Neveu, J., Lane, W., Hook, G., and Reisine, T. 2005 . Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer ' s disease . Biol Chem 386 : 931-940 .
12. Arbel, M., Yacoby, I., and Solomon, B. 2005 . Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies . Proc Natl Acad Sci U S A 102 : 7718-7723 .
13. Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A.L., Curran, E., Burgess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G., and Citron, M. 1999 . Beta-secretase cleavage of Alzheimer ' s amyloid precursor protein by the transmembrane aspartic protease BACE . Science 286 : 735-741 .
14. Sinha, S., Anderson, J.P., Barbour, R., Basi, G.S., Caccavello, R., Davis, D., Doan, M., Dovey, H.F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S.M., Wang, S., Walker, D., Zhao, J., McConlogue, L., and John, V. 1999 . Purification and cloning of amyloid precursor protein beta-secretase from human brain . Nature 402 : 537-540 .
15. Yan, R., Bienkowski, M.J., Shuck, M.E., Miao, H., Tory, M.C., Pauley, A.M., Brashier, J.R., Stratman, N.C., Mathews, W.R., Buhl, A.E., Carter, D.B., Tomasselli, A.G., Parodi, L.A., Heinrikson, R.L., and Gurney, M.E. 1999 . Membrane-anchored aspartyl protease with Alzheimer ' s disease beta-secretase activity . Nature 402 : 533-537 .
16. Hussain, I., Powell, D., Howlett, D.R., Tew, D.G., Meek, T.D., Chapman, C., Gloger, I.S., Murphy, K.E., Southan, C.D., Ryan, D.M., Smith, T.S., Simmons, D.L., Walsh, F.S., Dingwall, C., and Christie, G. 1999 . Identification of a novel aspartic protease (Asp 2) as beta-secretase . Mol Cell Neurosci 14 : 419-427 .
17. Citron, M. 2002 . Beta-secretase as a target for the treatment of Alzheimer ' s disease . J Neurosci Res 70 : 373-379 .
18. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D.R., Price, D.L., and Wong, P.C. 2001 . BACE1 is the major beta-secretase for generation of Abeta peptides by neurons . Nat Neurosci 4 : 233-234 .
19. Bennett, B.D., Babu-Khan, S., Loeloff, R., Louis, J.C., Curran, E., Citron, M., and Vassar, R. 2000 . Expression analysis of BACE2 in brain and peripheral tissues . J Biol Chem 275 : 20647-20651 .
20. Luo, Y., Bolon, B., Kahn, S., Bennett, B.D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., Martin, L., Louis, J.C., Yan, Q., Richards, W.G., Citron, M., and Vassar, R. 2001 . Mice deficient in BACE1, the Alzheimer ' s beta-secretase, have normal phenotype and abolished beta-amyloid generation . Nat Neurosci 4 : 231-232 .
21. Roberds, S.L., Anderson, J., Bas, G., Bienkowski, M.J., Branstetter, D.G., Chen, K.S., Freedman, S.B., Frigon, N.L., Games, D., Hu, K., Johnson-Wood, K., Kappenman, K.E., Kawabe, T.T., Kola, I., Kuehn, R., Lee, M., Liu, W., Motter, R., Nichols, N.F., Power, M., Robertson, D.W., Schenk, D., Schoor, M., Shopp, G.M., Shuck, M.E., Sinha, S., Svensson, K.A., Tatsuno, G., Tintrup, H., Wijsman, J., Wright, S., and McConlogue, L. 2001 . BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer ' s disease therapeutics . Hum Mol Genet 10 : 1317-1324 .
22. Pangalos, M.N., Jacobsen, S.J., and Reinhart, P.H. 2005 . Disease modifying strategies for the treatment of Alzheimer ' s disease targeted at modulating levels of the beta-amyloid peptide . Biochem Soc Trans 33 : 553-558 .
23. Dewachter, I. and Van Leuven, F. 2002 . Secretases as targets for the treatment of Alzheimer ' s disease: the prospects . Lancet Neurol 1 : 409-416 .
24. Capell, A., Meyn, L., Fluhrer, R., Teplow, D.B., Walter, J., and Haass, C. 2002 . Apical sorting of beta-secretase limits amyloid beta-peptide production . J Biol Chem 277 : 5637-5643 .
25. Lichtenthaler, S.F., Dominguez, D.I., Westmeyer, G.G., Reiss, K., Haass, C., Saftig, P., De Strooper, B., and Seed, B. 2003 . The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1 . J Biol Chem 278 : 48713-48719 .
26. Kitazume, S., Tachida, Y., Oka, R., Kotani, N., Ogawa, K., Suzuki, M., Dohmae, N., Takio, K., Saido, T.C., and Hashimoto, Y. 2003 . Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer ' s beta-secretase (BACE1) . J Biol Chem 278 : 14865-14871 .
27. Pastorino, L., Ikin, A.F., Lamprianou, S., Vacaresse, N., Revelli, J.P., Platt, K., Paganetti, P., Mathews, P.M., Harroch, S., and Buxbaum, J.D. 2004 . BACE (beta-secretase) modulates the processing of APLP2 in vivo . Mol Cell Neurosci 25 : 642-649 .
28. Willem, M., Garratt, A.N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., and Haass, C. 2006 . Control of peripheral nerve myelination by the beta-secretase BACE1 . Science 314 : 664-666 .
29. Ohno, M., Sametsky, E.A., Younkin, L.H., Oakley, H., Younkin, S.G., Citron, M., Vassar, R., and Disterhoft, J.F. 2004 . BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer ' s disease . Neuron 41 : 27-33 .
30. Laird, F.M., Cai, H., Savonenko, A.V., Farah, M.H., He, K., Melnikova, T., Wen, H., Chiang, H.C., Xu, G., Koliatsos, V.E., Borchelt, D.R., Price, D.L., Lee, H.K., and Wong, P.C. 2005 . BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions . J Neurosci 25 : 11693-11709 .
31. Hook, V.Y., Kindy, M., and Hook, G. 2008 . Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein . J Biol Chem 283 : 7745-7753 .
32. Koo, E.H. and Squazzo, S.L. 1994 . Evidence that production and release of amyloid beta-protein involves the endocytic pathway . J Biol Chem 269 : 17386-17389 .
33. Perez, R.G., Soriano, S., Hayes, J.D., Ostaszewski, B., Xia, W., Selkoe, D.J., Chen, X., Stokin, G.B., and Koo, E.H. 1999 . Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42 . J Biol Chem 274 : 18851-18856 .
34. Nixon, R.A., Mathews, P.M., and Cataldo, A.M. 2001 . The neuronal endosomal-lysosomal system in Alzheimer ' s disease . J Alzheimers Dis 3 : 97-107 .
35. Chyung, J.H. and Selkoe, D.J. 2003 . Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface . J Biol Chem 278 : 51035-51043 .
36. Perez, R.G., Squazzo, S.L., and Koo, E.H. 1996 . Enhanced release of amyloid beta-protein from codon 670/671 " Swedish " mutant beta-amyloid precursor protein occurs in both secretory and endocytic pathways . J Biol Chem 271 : 9100-9107 .
37. Soriano, S., Chyung, A.S., Chen, X., Stokin, G.B., Lee, V.M., and Koo, E.H. 1999 . Expression of beta-amyloid precursor protein-CD3gamma chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments . J Biol Chem 274 : 32295-32300 .
38. Huse, J.T., Pijak, D.S., Leslie, G.J., Lee, V.M., and Doms, R.W. 2000 . Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer ' s disease beta-secretase . J Biol Chem 275 : 33729-33737 .
39. Walter, J., Fluhrer, R., Hartung, B., Willem, M., Kaether, C., Capell, A., Lammich, S., Multhaup, G., and Haass, C. 2001 . Phosphorylation regulates intracellular trafficking of beta-secretase . J Biol Chem 276 : 14634-14641 .
40. Koo, E.H., Squazzo, S.L., Selkoe, D.J., and Koo, C.H. 1996 . Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody . J Cell Sci 109 ( Pt 5 ): 991-998 .
41. Kinoshita, A., Fukumoto, H., Shah, T., Whelan, C.M., Irizarry, M.C., and Hyman, B.T. 2003 . Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes . J Cell Sci 116 : 3339-3346 .
42. Tam, J.P. 1988 . Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system . Proc Natl Acad Sci U S A 85 : 5409-5413 .
43. Wang, C.Y., Looney, D.J., Li, M.L., Walfield, A.M., Ye, J., Hosein, B., Tam, J.P., and Wong-Staal, F. 1991 . Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen . Science 254 : 285-288 .
44. Posnett, D.N., McGrath, H., and Tam, J.P. 1988 . A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain . J Biol Chem 263 : 1719-1725 .
45. Haass, C., Lemere, C.A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., and Selkoe, D.J. 1995 . The Swedish mutation causes early-onset Alzheimer ' s disease by beta-secretase cleavage within the secretory pathway . Nat Med 1 : 1291-1296 .
46. Thinakaran, G., Teplow, D.B., Siman, R., Greenberg, B., and Sisodia, S.S. 1996 . Metabolism of the " Swedish " amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the " beta-secretase " site occurs in the Golgi apparatus . J Biol Chem 271 : 9390-9397 .
47. Gruninger-Leitch, F., Schlatter, D., Kung, E., Nelbock, P., and Dobeli, H. 2002 . Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases . J Biol Chem 277 : 4687-4693 .
48. Nordstedt, C., Caporaso, G.L., Thyberg, J., Gandy, S.E., and Greengard, P. 1993 . Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells . J Biol Chem 268 : 608-612 .
49. Ehehalt, R., Keller, P., Haass, C., Thiele, C., and Simons, K. 2003 . Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts . J Cell Biol 160 : 113-123 .
50. Kim, M.L., Zhang, B., Mills, I.P., Milla, M.E., Brunden, K.R., and Lee, V.M. 2008 . Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo . J Neurosci 28 : 12052-12061 .
51. Rakover, I., Arbel, M., and Solomon, B. 2007 . Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain Abeta levels . Neurodegener Dis 4 ( 5 ): 392-402 .
52. Dolev, I. and Michaelson, D.M. 2004 . A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade . Proc Natl Acad Sci U S A 101 : 13909-13914 .
53. Yasojima, K., Akiyama, H., McGeer, E.G., and McGeer, P.L. 2001 . Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide . Neurosci Lett 297 : 97-100 .
54. Cook, D.G., Leverenz, J.B., McMillan, P.J., Kulstad, J.J., Ericksen, S., Roth, R.A., Schellenberg, G.D., Jin, L.W., Kovacina, K.S., and Craft, S. 2003 . Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer ' s disease is associated with the apolipoprotein E-epsilon4 allele . Am J Pathol 162 : 313-319 .
55. Maruyama, M., Higuchi, M., Takaki, Y., Matsuba, Y., Tanji, H., Nemoto, M., Tomita, N., Matsui, T., Iwata, N., Mizukami, H., Muramatsu, S., Ozawa, K., Saido, T.C., Arai, H., and Sasaki, H. 2005 . Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer ' s disease . Ann Neurol 57 : 832-842 .
56. Moechars, D., Gilis, M., Kuiperi, C., Laenen, I., and Van Leuven, F. 1998 . Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs . Neuroreport 9 : 3561-3564 .
57. Chang, W.P., Koelsch, G., Wong, S., Downs, D., Da, H., Weerasena, V., Gordon, B., Devasamudram, T., Bilcer, G., Ghosh, A.K., and Tang, J. 2004 . In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors . J Neurochem 89 : 1409-1416 .
58. Wilcock, D.M., Rojiani, A., Rosenthal, A., Subbarao, S., Freeman, M.J., Gordon, M.N., and Morgan, D. 2004 . Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage . J Neuroinflammation 1 : 24 .
59. Morgan, D. 2005 . Mechanisms of A beta plaque clearance following passive A beta immunization . Neurodegener Dis 2 : 261-266 .
60. Espeseth, A.S., Xu, M., Huang, Q., Coburn, C.A., Jones, K.L., Ferrer, M., Zuck, P.D., Strulovici, B., Price, E.A., Wu, G., Wolfe, A.L., Lineberger, J.E., Sardana, M., Tugusheva, K., Pietrak, B.L., Crouthamel, M.C., Lai, M.T., Dodson, E.C., Bazzo, R., Shi, X.P., Simon, A.J., Li, Y., and Hazuda, D.J. 2005 . Compounds that bind APP and inhibit Abeta processing in vitro suggest a novel approach to Alzheimer disease therapeutics . J Biol Chem 280 : 17792-17797 .
61. Inglese, J., Samama, P., Patel, S., Burbaum, J., Stroke, I.L., and Appell, K.C. 1998 . Chemokine receptor-ligand interactions measured using time-resolved fluorescence . Biochemistry 37 : 2372-2377 .
62. Ohyagi, Y. 2008 . Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer ' s disease . Curr Alzheimer Res 5 : 555-561 .
63. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 1996 . Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer ' s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer ' s disease . Nat Med 2 : 864-870 .